Kai Pharmaceuticals

This study tested whether a single dose of an experimental drug called KAI-1678 could safely reduce severe nerve pain in people with postherpetic neuralgia, a painful condition that can follow shingles. It was a small, Phase 2 trial that compared the drug against a placebo and an…

This study tested whether a single dose of an experimental drug called KAI-1678 could reduce pain in people with long-term spinal cord injuries. Five participants received either the drug or a placebo in a random order to see which worked better. The main goal was to see if the d…